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Health information is the glue that holds a health
system together. In most countries stronger, more
integrated information systems are required [1].
The rheumatologic community is in a leading position
for the development of International Classification of
Functioning, Disability and Health (ICF) Core Sets and
the research into the validity and application of the ICF. We
can be proud of this achievement, but not all of us are
aware of this new development. What is the ICF?
Rheumatologic conditions have major impact on patients.
Apart from symptoms such as pain, stiffness, and fatigue,
patients are limited in activities and restricted in participation
in society [2]. When unable to continue paid work, for
example, there are important consequences for the patients,
their families, but also for society. A major goal of the
management of rheumatic diseases is to maintain or restore
functioning. This contributes to the well-being of the
patients, their families, and other caregivers. It is clear that
maintaining function requires more than control of disease
activity. By using the ICF, which was developed by the
World Health Organization (WHO), we can obtain infor-
mation on all three areas that are important for global
functioning: body functions and structures, activities
(actions by an individual), and participation (involvement
in life situations) [3].
The ICF is one of the three reference classification
systems that were proposed and developed by the WHO
and belong to the Family of International Classifications.
The main aim of the classification systems is to improve
integration of health information. The International Classi-
fication of Diagnosis (ICD) is well known and widely
applied [4]. The ICF was developed from the older
International Classification of Impairments, Disabilities,
and Handicaps (ICIDH) and accepted in 2001 [3]. It is
increasingly recognized as an important classification in
clinical medicine, outcome research, and healthcare orga-
nization. The International Classification of Health Inter-
ventions (ICHI) is proposed as the newest member of the
family, and its development has just started [1].
The WHO aims to implement effectively the ICF
worldwide and formulated strategic directions in which the
three following are the most relevant: (1) The ICF has to
become the framework to classify function, (2) easy-to-use
ICF linked instruments should be developed to assess
functional outcome as well as effectiveness of interventions,
and (3) the level and quality of implementation of the ICF
should be improved to increase quality and comparability
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of health and disability statistics for national and interna-
tional purposes [1].
In this review, the ICF framework and classification are
explained from the broader perspective of the history of
outcome assessment. Healthcare areas in which the ICF can
be useful will be addressed. Finally, the strengths of the ICF
will be challenged by the research agenda.
The ICF as the universal framework for functioning:
a historical view
For centuries, diagnostic and outcome assessments in
medicine were limited to the assessment of the direct
physiological consequence of the disease. Research con-
centrated on methods to evaluate the biological disease
process such as body temperature or blood pressure,
identification of microbial pathogens, or detection of
laboratory abnormalities reflecting organ dysfunction. The
need to measure and quantify the effect of (ill) health on
human well-being and functioning is a recent phenomenon
in the long history of medicine. This was inspired by the
need to be able to measure the function of a patient as well
as the effects of treatments. In rheumatoid arthritis (RA),
the first classification of function was introduced in 1949
by Steinbrocker [5], and the first instrument to measure
functioning, the Health Assessment Questionnaire (HAQ),
was proposed by Fries in 1980 [6]. Since then, many other
instruments emerged to measure functioning either disease
specific [7–10], generic [11, 12], or for specific aspects of
functioning such as hand function in RA [13–15]. Howev-
er, these classifications and instruments are based on older
models of functioning, mainly known as the impairment–
disability–handicap concept (Fig. 1) and have several
drawbacks [16, 17]. They apply a negative terminology,
are unidirectional, and reflect the narrow biomedical view
on function by ignoring the importance of environmental
(social) and personal factors for functioning. These short-
comings are addressed by the ICF framework.
Functioning is now understood as the human experience
in relation to body functions and structures, activities and
participation in the interaction with health conditions,
personal and environmental factors (Fig. 2). By using the
term participation instead of handicap, a positive terminol-
ogy is proposed. By including the environmental and
personal factors, the bio-psychosocial model is accepted
[2]. Finally, the different components of the framework
recognize human functioning as a complex interaction of
the different areas. It is clear that the ICF framework is in
line with the WHO’s definition of health that includes
“physical, mental and social wellbeing” [18]. Although
developed to describe functioning of people with a (ill)
health condition, it may indeed also be applied for healthy
subjects because functioning is a universal experience.
Why is the ICF called “the universal” classification
for functioning?
The ICF Core Sets
The ICF offers a framework that conceptualizes functioning
but is also a classification comprising 1,454 descriptions
that cover all aspects of functioning and are called ICF
categories. These categories are structured hierarchically
into different chapters that, on their turn, belong to the ICF
components: body functions and structures (categories
designed a number preceded by “b” or “s” respectively),
activities and participation (categories designed as a
number preceded by “d”), environmental factors (categories
designed as a number preceded by “e”), and personal
factors (categories not yet defined; Fig. 3).
To apply the ICF in practice, either in patients with a
specific condition (like RA) or in specific healthcare
situations (like acute or post-acute care), ICF Core Sets are
being developed. These comprise specific categories relevant
for a particular condition or a specific situation [19].
At present, first versions of ICF Core Sets have been
published for 12 chronic health conditions among which 5 are
for musculoskeletal diseases: RA, osteoporosis, osteoarthritis,
low back pain, and chronic widespread pain [20–24]. The first
versions of these ICF Core Sets are currently undergoing a
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Fig. 1 Representation of the historical view on functioning that
represents the typical biomedical model of disease
ICD 10 health condition
body functions & structures
environmental factors personal factors
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Fig. 2 The current framework of disability—the WHO ICF
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project with EULAR for the five musculoskeletal ICF Core
Sets. Additional ICF Core Sets for musculoskeletal disease
are currently also being developed for psoriatic arthritis,
ankylosing spondylitis, scleroderma, lupus, and gout [25, 26].
For the acute hospital and early post-acute rehabilitation
facilities, ICF Core Sets have been developed for musculo-
skeletal, cardiovascular, and neurological conditions [27].
Arthritis-specific ICF Core Sets have been developed for the
acute and early post-acute situation [28, 29].
Upon completion and experience with the development
of these ICF Core Sets, a Generic ICF Core Set is being
developed that aims to include categories necessary to
represent the experience of human functioning irrespective
of the underlying health condition.
When developing the ICF Core Sets, a standardized
approach is applied in which the perspective of patients,
different types of health care providers, and outcome
researchers are taken into account [30]. As the categories of
the specific ICF Core Sets originate from the universal ICF,
the classifications can be easily understood across profes-
sionals and across conditions. The common definition of the
categories and the standardized development of the Core
Sets explains why the ICF is called a universal classification.
How to measure the ICF categories
It should be emphasized that Core Sets aim at first to define
“what” should be assessed when classifying function. “How”
these categories should be assessed is a different issue.
It is specifically mentioned in the WHO business report that
it is by no means the aim of the ICF to replace validated
existing instruments. In contrast, it is likely that they will
have an essential role to measure particular parts of the ICF.
The ICF classification provides for each category an
optional scoring, the so-called ICF qualifiers. Qualifiers are
numeric codes that specify the extent or the magnitude of
the functioning or disability in that category or the extent to
which an environmental factor is a facilitator or barrier. Such
a qualifier may be directly be applied or can serve as
reference scale if specific measures are being used. Accord-
ing to the ICF qualifier, the level of impairments in body
functions and body structures or limitations or restrictions
in activities and participation can be indicated on a 0 (no) to
4 (complete) scale. A “c” indicates the category is impaired
or limited as a consequence of comorbidity, “8” that the
level of impairment cannot be specified, and “9” that the
category is not applicable. For the environmental factors,
patients can specify the category is a barrier (−) or a
facilitator (+) [31]. The qualifiers can be directly applied to
the categories or can serve as reference scale if specific
measures are being used to qualify the categories.
The direct application of the ICF qualifier is challenging.
First, the language of the ICF is sometimes difficult to
understand. Secondly, the number of response categories
may exceed the number relevant for patients and health
professionals in clinical practice. Therefore, it is often
preferable to use reliable and validated instruments for the
measurement of specific ICF categories. While such instru-
Structure of ICF classification



























“b” or “s” “d” “e” (letter followed by a figure)
Fig. 3 Structure of the ICF
classification
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ments often differ on important aspects from the ICF
classification, they can be very useful to operationalize the
ICF in specific situations and for specific categories.
Figure 4 represents how the ICF is the “universal” interface
between agreed upon categories and existing measures.
Applications of the ICF Core Sets
The main stakeholders of the ICF are clinicians, researchers,
and decision makers on the governmental level and, last but
not least, governments. Most certainly, also patient organi-
zations, healthcare organizations (health insurance compa-
nies, home care organizations, social security services), and
media systems can benefit from the ICF [2].
As the ICF can classify functioning at the group but also
at the individual level, it can be used in clinical practice.
Especially in rehabilitation medicine, the comprehensive
approach contributes to the planning of tailor made care for
patients within the framework of the bio-psychosocial
model. The assessment for vocational rehabilitation of a
patient with RA, for example, requires careful evaluation of
impairments in body functions (such as pain, energy level,
sleep) and body structures (such as damage to the hand
joints), limitations in activities (fine hand use, walking) and
participation (using transportation services, self-care), but
also identification of relevant environmental factors (med-
ication, adaptations, attitudes of colleagues, attitudes of
family members) and personal factors (age, marital state,
educational level, coping strategies, illness perceptions)
[32]. Identification of the individualized relevant categories
will make it possible to set priorities for treatment and to
identify the health professionals responsible to execute each
of the identified priorities [33]. While the contribution of
allied health professionals is recognized, the ICF will help
defining the specific role and responsibilities of each
professional for the different categories [34]. The common
ICF framework and language will improve not only
communication among the different healthcare providers
but also communication with the patients and nonmedical
environment such as family and employers.
For researchers with an interest in outcome assessment,
the ICF offers challenging opportunities. ICF Core Sets are
useful for the design, the evaluation, and the reporting of
studies examining the longitudinal course of disease or the
efficacy and effectiveness of interventions. In the study
design, ICF-based comparisons of candidate measures will
help to select aspects of functioning, which most appropri-
ately cover the patients’ problems that should be improved.
Researchers have to pinpoint the targets and explanatory
Fig. 4 The ICF as interface
between concepts relevant for
functioning and existing instru-
ments measuring function
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variables. Currently, we often lack an understanding of the
mechanism that leads to progression of disease or improve-
ment based on an intervention. The ICF offers an opportu-
nity that not only enables to report about statistical and
clinically relevant differences but also to demonstrate the
mechanism of changes (over time or during interventions) on
the level of functioning. Such analyses are only possible if at
least a minimum set of variables covering all aspects relevant
to people with the condition are covered. In addition, the
ICF-based approach to follow cohorts or intervention studies
will enable comparison of studies not only in people with the
same condition but also across diseases when considering
the Generic ICF Core Set in the study design.
From the perspective of the governments and healthcare
organizations, there is a great interest in the ICF. For the
WHO, it has a priority to demonstrate the utility and
feasibility of using ICF in areas of strategic importance such
as health and disability reporting, outcome measurement for
clinical and epidemiological use, and disability assessment
and certification by 2008. ICF-based data sets including ICF
population norms and disability prevalence rates should be
available by 2010. Healthcare organizations explore the
application of the ICF for disability assessments, eligibility
of technical aids and home care, and organization of social
services. Such data will contribute to insight in planning of
social security systems and home care, eligibility assessment
for disability pensions, and technical aids.
Future challenges
While it is obvious that the ICF has made tremendous steps
forward since its conception, it is clear at the same time that
there is still a challenging way to go.
The first priority is to develop a classification for
personal factors and the development of the Generic Core
Set. As for any instrument, the classification has to prove it
can pass the validity filter, especially with regard to
discrimination and feasibility. From limited research, it is
suggested that the reliability can be improved, probably
because the ICF language is difficult to understand and
because the qualifiers show differential functioning [35].
This is especially true for many categories referring to
participation and for most environmental factors that were
relevant in all Core Sets and for which no other but ICF-
based classifications exist. While there are many studies
that address work participation, few validated instruments
exist to assess absenteeism [36–39]. Even fewer instru-
ments are developed to assess participation in nonwork-
related social activities, except some items of generic
instruments such as short-form (SF) 36 [12] and of the
Arthritis Impact Measurement Scales-2 (AIMS2) [40].
To improve feasibility, expanding the efforts to increase
understanding and application of the ICF among a wider
audience are still necessary. On this line, the exact approach
on how existing measures can be integrated into the ICF
classification needs further clarification and consensus.
This will include the exploration of statistical methods to
handle hierarchical data and complex relationship between
the categories belonging to the components.
Conclusion
The adoption of the ICF in 2001 as a framework and
classification was the recognition of the importance of the
bio-psychosocial perspective to account for the human
experience of functioning. Being a universal language, the
ICF will improve our insight into the complexity of human
functioning, help tailor-made care for the individual patient,
and improve design and reporting of observational and
interventional studies. The rheumatologic community has
to be merited to be in a leading position for the
development of Core Sets and the research into validity
and application of the ICF. This illustrates again how, for
the rheumatologist, the patient needs to be the starting as
well as endpoint of his devotion.
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